{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:49:51Z","timestamp":1777639791284,"version":"3.51.4"},"reference-count":11,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2019,8,26]]},"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:p>Factor X deficiency is a rare bleeding disorder that can be associated with life-threatening bleeding events. Factor X deficiency can either be inherited or acquired. Acquired cases of factor X deficiency can be seen in patients with plasma cell dyscrasias as well as amyloidosis. Coagulopathy, with clinically relevant bleeding events, although rare, is not an unusual phenomenon for patients with systemic amyloidosis. However, clinically relevant bleeding in patients with symptomatic multiple myeloma, without associated amyloidosis, has not been reported in literature before. We present a rare case of multiple myeloma without concomitant amyloidosis that presented with life-threatening bleeding from acquired deficiency of factor X and responded remarkably to treatment for underlying multiple myeloma. This case not only highlights the diagnostic workup required in patients with factor X deficiency but also provides the principles of management of acquired coagulopathy in plasma cell dyscrasias.<\/jats:p>","DOI":"10.1136\/bcr-2019-230249","type":"journal-article","created":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T21:07:20Z","timestamp":1568668040000},"page":"e230249","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Acquired factor X deficiency in a patient with multiple myeloma: a rare case highlighting the significance of comprehensive evaluation and the need for antimyeloma therapy for bleeding diathesis"],"prefix":"10.1136","volume":"12","author":[{"given":"Samuel Benjamin","family":"Reynolds","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Louisville School of Medicine, Louisville, Kentucky, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhaval Pravinkumar","family":"Maghavani","sequence":"additional","affiliation":[{"name":"Department of Medicine, Grant Medical College and Sir JJ Group of Hospitals, Mumbai, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamza","family":"Hashmi","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology and Hematology, University of Louisville, Louisville, Kentucky, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,9,16]]},"reference":[{"key":"2025082802543667000_12.9.e230249.1","unstructured":"Vincent Rajkumar S , Dimopoulos MA , Palumbo A , et al . International myeloma working group updated criteria for the diagnosis of multiple myeloma."},{"key":"2025082802543667000_12.9.e230249.2","doi-asserted-by":"crossref","first-page":"e530","DOI":"10.1038\/bcj.2017.14","article-title":"Discrepancies between the percentage of plasma cells in bone marrow aspiration and BM biopsy: Impact on the revised IMWG diagnostic criteria of multiple myeloma","volume":"7","author":"Lee","year":"2017","journal-title":"Blood Cancer J"},{"key":"2025082802543667000_12.9.e230249.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2015.11.007"},{"key":"2025082802543667000_12.9.e230249.4","doi-asserted-by":"publisher","DOI":"10.1054\/blre.2002.0191"},{"key":"2025082802543667000_12.9.e230249.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2012.02773.x"},{"key":"2025082802543667000_12.9.e230249.6","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.4067\/S0034-98872015001100016","article-title":"[Isolated factor X deficiency in chronic myelomonocytic leukemia: Report of one case]","volume":"143","author":"Zelada","year":"2015","journal-title":"Rev Med Chil"},{"key":"2025082802543667000_12.9.e230249.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197707142970203"},{"key":"2025082802543667000_12.9.e230249.8","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.40.23468"},{"issue":"Suppl 1","key":"2025082802543667000_12.9.e230249.9","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1016\/j.mjafi.2014.01.007","article-title":"Inherited factor X (Stuart-Prower Factor) deficiency and its management","volume":"71","author":"Chatterjee","year":"2015","journal-title":"Med J Armed Forces India"},{"key":"2025082802543667000_12.9.e230249.10","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1056\/NEJM197911083011907","article-title":"Factor X deficiency in primary amyloidosis: resolution after splenectomy","volume":"301","author":"Greipp","year":"1979","journal-title":"N Engl J Med"},{"key":"2025082802543667000_12.9.e230249.11","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.6.1885"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2019-230249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T09:54:43Z","timestamp":1756374883000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2019-230249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":11,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9,16]]},"published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.1136\/bcr-2019-230249"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2019-230249","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}